France Myocardial Infarction Market
France Myocardial Infarction Market Size, Share & Trends Analysis Report by Treatment Type (Pharmacological Treatment, Interventional Procedures, Adjunct & Supportive Care), by Medical Device Type (Left Ventricular Assist Device, Pacemaker, Catheters, Implantable Cardioverter Defibrillator, Others), by End-Use Industry (Hospitals, Specialty Centres, ASCs), and Forecast Period (2026–2035)
Industry Overview
France myocardial infarction market was valued at approximately $242.3 million in 2025 and is projected to reach $388.3 million by 2035, growing at a CAGR of 4.9% from 2026 to 2035. Myocardial infarction, commonly referred to as a heart attack, continues to be a major cause of morbidity and mortality, driving the need for advanced treatment and continuous monitoring solutions. The market encompasses a wide range of medical devices, including pacemakers, catheters, implantable cardioverter defibrillators, and ventricular assist devices, along with pharmacological therapies and supportive care services. Growth is primarily driven by an aging population and the rising prevalence of lifestyle-related conditions such as hypertension, obesity, and diabetes. Furthermore, advancements in interventional cardiology and the increasing adoption of minimally invasive procedures are improving patient outcomes, reducing hospital stays, and enhancing overall treatment efficiency.
Technological innovation remains a key factor shaping the market landscape. In January 2026, AliveCor received FDA clearance for new cardiac determinations in its Kardia 12L ECG system, strengthening its AI-enabled diagnostic capabilities for detecting conditions such as acute myocardial infarction and enabling faster clinical decision-making. The company’s expansion into Europe, including France, is expected to enhance early detection and improve cardiac care delivery. Similarly, in August 2025, GE HealthCare introduced its AI-powered Vivid Pioneer cardiovascular ultrasound system, which received CE Mark approval for use across European healthcare systems. Equipped with advanced automation and 4D imaging, the system enhances diagnostic accuracy and workflow efficiency. Together, these innovations are improving early diagnosis, streamlining treatment pathways, and supporting the continued growth of the myocardial infarction market in France.
Market Dynamics
Interventional Procedures Lead France MI Market with Improved PCI Outcomes
Interventional procedures continue to dominate the france myocardial infarction market due to their effectiveness in restoring blood flow and reducing mortality. Techniques such as angioplasty and stent placement are widely adopted across hospitals for acute MI management. In October 2025, a PubMed study reported that P2Y12 inhibitor pretreatment significantly reduced in-hospital stent thrombosis in patients undergoing PCI. The real-world findings highlight improved clinical outcomes through optimized antiplatelet therapy. This advancement strengthens both interventional and pharmacological treatment strategies within France’s MI care landscape.
Advanced Implantable Cardiac Devices Strengthen Post-MI Care in France
Implantable cardiac devices such as pacemakers and implantable cardioverter defibrillators are gaining traction for long-term cardiac monitoring and rhythm management. In January 2024, Medtronic received CE Mark approval for its next-generation Micra AV2 and VR2 leadless pacemakers, enabling deployment across Europe, including France. These devices offer enhanced battery life and minimally invasive implantation, improving patient outcomes. Their adoption supports effective management of cardiac rhythm disorders. This advancement indirectly strengthens post-myocardial infarction care by addressing arrhythmia-related complications in France.
Market Segmentation
- Based on treatment type, the market is segmented into pharmacological treatment, interventional procedures, and adjunct & supportive care.
- Based on medical device type, the market is segmented into left ventricular assist device, pacemaker, catheters, implantable cardioverter defibrillator, and others.
- Based on end-user, the market is segmented into hospitals, speciality centres, and ASCs.
Hospitals Lead as the Dominant End-User Segment
Hospitals hold the largest share of the market due to a high volume of myocardial infarction cases requiring immediate medical attention. Their advanced infrastructure enables efficient emergency cardiac care and complex interventional procedures. Most PCI procedures and device implantations are conducted within hospital settings. The presence of skilled healthcare professionals further strengthens their position in acute care delivery. As a result, hospitals remain the primary contributors to overall market revenue.
Market Players Outlook
The major companies operating in the French myocardial infarction market include Johnson & Johnson, Abbott, Medtronic, Siemens Healthineers, and GE HealthCare, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In September 2024, Boston Scientific welcomed a statement from the S. Food and Drug Administration reaffirming that drug-eluting stents remain safe and effective for approved cardiovascular indications. The announcement reinforces confidence in stent-based interventions, which are widely used in percutaneous coronary intervention for myocardial infarction treatment. This development supports continued adoption of interventional cardiology devices, strengthening the myocardial infarction treatment landscape in France.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Key companies operating in the French myocardial infarction market
- Based on the availability of data, information related to new protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- France Myocardial Infarction Market Sales Analysis – Treatment Type | Device Type | End User ($ Million)
- France Myocardial Infarction Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach Analytics
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key France Myocardial Infarction Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers of France Myocardial Infarction Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For France Myocardial Infarction Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – France Myocardial Infarction Market Revenue and Share by Manufacturers
- France Myocardial Infarction Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- France Myocardial Infarction Market Sales Analysis Treatment Type ($ Million)
- Pharmacological Treatment
- Interventional Procedures
- Adjunct & Supportive Care
- France Myocardial Infarction Market Sales Analysis Device Type ($ Million)
- Left Ventricular Assist Device
- Pacemaker
- Catheters
- Implantable Cardioverter Defibrillator
- Others
- France Myocardial Infarction Market Sales Analysis End User ($ Million)
- Hospitals
- Specialty Centres
- ASCs
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AngioDynamics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Balt Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BIOTRONIK SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Edwards Lifesciences Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurocor Tech GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FineHeart SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Getinge AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LivaNova PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort CRM
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Robocath
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- STENTYS SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Straub Medical AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teleflex Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vygon SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- L. Gore & Associates
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. France Myocardial Infarction Market Research and Analysis By Treatment Type, 2025-2035($ Million)
2. France Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025-2035($ Million)
3. France Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025-2035($ Million)
4. France Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025-2035($ Million)
5. France Myocardial Infarction Market Research and Analysis By Device Type, 2025-2035($ Million)
6. France Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025-2035($ Million)
7. France Myocardial Infarction Pacemaker Market Research and Analysis, 2025-2035($ Million)
8. France Myocardial Infarction Catheters Market Research and Analysis, 2025-2035($ Million)
9. France Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025-2035($ Million)
10. France Myocardial Infarction Others Market Research and Analysis, 2025-2035($ Million)
11. France Myocardial Infarction Market Research and Analysis By End User, 2025-2035($ Million)
12. France Myocardial Infarction For Hospitals Market Research and Analysis, 2025-2035($ Million)
13. France Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025-2035($ Million)
14. France Myocardial Infarction For ASCs Market Research and Analysis, 2025-2035($ Million)
1. France Myocardial Infarction Market Research and Analysis By Treatment Type, 2025 Vs 2035 ($ Million)
2. France Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025 Vs 2035 ($ Million)
3. France Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025 Vs 2035 ($ Million)
4. France Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025 Vs 2035 ($ Million)
5. France Myocardial Infarction Market Research and Analysis By Device Type, 2025 Vs 2035 ($ Million)
6. France Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025 Vs 2035 ($ Million)
7. France Myocardial Infarction Pacemaker Market Research and Analysis, 2025 Vs 2035 ($ Million)
8. France Myocardial Infarction Catheters Market Research and Analysis, 2025 Vs 2035 ($ Million)
9. France Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025 Vs 2035 ($ Million)
10. France Myocardial Infarction Others Market Research and Analysis, 2025 Vs 2035 ($ Million)
11. France Myocardial Infarction Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
12. France Myocardial Infarction For Hospitals Market Research and Analysis, 2025 Vs 2035 ($ Million)
13. France Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025 Vs 2035 ($ Million)
14. France Myocardial Infarction For ASCs Market Research and Analysis, 2025 Vs 2035 ($ Million)
- Printable version
- No restriction to number of users within the company
